Refractory Hypoglycaemia in Hepatocellular Carcinoma Treated with TACE Leading to Tumour Lysis Syndrome- A Double Trouble
Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer. Hypoglycaemia is a well-established paraneoplastic manifestation of HCC. Cytoreduction by surgery or Transarterial Chemoembolisation (TACE) has been effective treatment options in such cases when conservative treatment f...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2022-01-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://www.jcdr.net/articles/PDF/15923/52274_CE(Ra1)_F(SS)_PF1(SC_SS)_PFA(SC_KM)_PN(KM).pdf |
_version_ | 1828049016043077632 |
---|---|
author | Saurabh kumar Ishita B Sen Vivek Vij Ashish Singhal Ajitabh Srivastava |
author_facet | Saurabh kumar Ishita B Sen Vivek Vij Ashish Singhal Ajitabh Srivastava |
author_sort | Saurabh kumar |
collection | DOAJ |
description | Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer. Hypoglycaemia is a well-established paraneoplastic manifestation of HCC. Cytoreduction by surgery or Transarterial Chemoembolisation (TACE) has been effective treatment options in such cases when conservative treatment fails. Tumour Lysis Syndrome (TLS) is an oncological emergency following treatment of malignancies with high cell turnover and can be seen in liver-directed therapy in the form of both ablative therapies and transarterial therapies for HCC. Authors present a rare case of 65-year-old male, with HCC presented with symptoms of refractory hypoglycaemia which was managed by TACE procedure with further patient developing TLS which was medically managed. |
first_indexed | 2024-04-10T19:04:42Z |
format | Article |
id | doaj.art-92921416518d4c87b3af5bf5322af6c1 |
institution | Directory Open Access Journal |
issn | 2249-782X 0973-709X |
language | English |
last_indexed | 2024-04-10T19:04:42Z |
publishDate | 2022-01-01 |
publisher | JCDR Research and Publications Private Limited |
record_format | Article |
series | Journal of Clinical and Diagnostic Research |
spelling | doaj.art-92921416518d4c87b3af5bf5322af6c12023-01-31T04:21:21ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2022-01-01161TD01TD0210.7860/JCDR/2022/52274.15923Refractory Hypoglycaemia in Hepatocellular Carcinoma Treated with TACE Leading to Tumour Lysis Syndrome- A Double TroubleSaurabh kumar0Ishita B Sen1Vivek Vij2Ashish Singhal3Ajitabh Srivastava4Consultant Interventional Radiologist, Department of Interventional Radiology, Fortis Memorial Research Institute, Gurugram, Haryana, India.Director, Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurugram, Haryana, India.Director, Department of Liver Transplant and Hepatobiliary Surgery, Fortis Memorial Research Institute, Gurugram, Haryana, India.Senior Consultant, Department of Liver Transplant and Hepatobiliary Surgery, Fortis Memorial Research Institute, Gurugram, Haryana, India.Senior Consultant, Department of Liver Transplant and Hepatobiliary Surgery, Fortis Memorial Research Institute, Gurugram, Haryana, India.Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer. Hypoglycaemia is a well-established paraneoplastic manifestation of HCC. Cytoreduction by surgery or Transarterial Chemoembolisation (TACE) has been effective treatment options in such cases when conservative treatment fails. Tumour Lysis Syndrome (TLS) is an oncological emergency following treatment of malignancies with high cell turnover and can be seen in liver-directed therapy in the form of both ablative therapies and transarterial therapies for HCC. Authors present a rare case of 65-year-old male, with HCC presented with symptoms of refractory hypoglycaemia which was managed by TACE procedure with further patient developing TLS which was medically managed.https://www.jcdr.net/articles/PDF/15923/52274_CE(Ra1)_F(SS)_PF1(SC_SS)_PFA(SC_KM)_PN(KM).pdfcytoreductionhepatomegalytransarterial chemoembolisation |
spellingShingle | Saurabh kumar Ishita B Sen Vivek Vij Ashish Singhal Ajitabh Srivastava Refractory Hypoglycaemia in Hepatocellular Carcinoma Treated with TACE Leading to Tumour Lysis Syndrome- A Double Trouble Journal of Clinical and Diagnostic Research cytoreduction hepatomegaly transarterial chemoembolisation |
title | Refractory Hypoglycaemia in Hepatocellular Carcinoma Treated with TACE Leading to Tumour Lysis Syndrome- A Double Trouble |
title_full | Refractory Hypoglycaemia in Hepatocellular Carcinoma Treated with TACE Leading to Tumour Lysis Syndrome- A Double Trouble |
title_fullStr | Refractory Hypoglycaemia in Hepatocellular Carcinoma Treated with TACE Leading to Tumour Lysis Syndrome- A Double Trouble |
title_full_unstemmed | Refractory Hypoglycaemia in Hepatocellular Carcinoma Treated with TACE Leading to Tumour Lysis Syndrome- A Double Trouble |
title_short | Refractory Hypoglycaemia in Hepatocellular Carcinoma Treated with TACE Leading to Tumour Lysis Syndrome- A Double Trouble |
title_sort | refractory hypoglycaemia in hepatocellular carcinoma treated with tace leading to tumour lysis syndrome a double trouble |
topic | cytoreduction hepatomegaly transarterial chemoembolisation |
url | https://www.jcdr.net/articles/PDF/15923/52274_CE(Ra1)_F(SS)_PF1(SC_SS)_PFA(SC_KM)_PN(KM).pdf |
work_keys_str_mv | AT saurabhkumar refractoryhypoglycaemiainhepatocellularcarcinomatreatedwithtaceleadingtotumourlysissyndromeadoubletrouble AT ishitabsen refractoryhypoglycaemiainhepatocellularcarcinomatreatedwithtaceleadingtotumourlysissyndromeadoubletrouble AT vivekvij refractoryhypoglycaemiainhepatocellularcarcinomatreatedwithtaceleadingtotumourlysissyndromeadoubletrouble AT ashishsinghal refractoryhypoglycaemiainhepatocellularcarcinomatreatedwithtaceleadingtotumourlysissyndromeadoubletrouble AT ajitabhsrivastava refractoryhypoglycaemiainhepatocellularcarcinomatreatedwithtaceleadingtotumourlysissyndromeadoubletrouble |